Chemical Formula: C21H27N

Chemical Formula C21H27N

Found 15 metabolite its formula value is C21H27N

Budipine

4,4-Diphenyl-1-tert-butylpiperidine hydrochloride

C21H27N (293.21433820000004)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C93038 - Cation Channel Blocker Budipine is an anti-parkinson agent. Budipine also is a substrate of P-glycoprotein (P-gp), is mediated the uptake into the brain by P-gp. Budipine also is N-methyl-d-aspartate (NMDA) antagonist, and has indirect dopaminergic effects through an improved dopamine release, the inhibition of monoamine oxidase type B (MAO-B). Budipine can be used for the research of CNS disorders include Parkinson disease[1].

   

Butriptyline

dimethyl(2-methyl-3-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)amine

C21H27N (293.21433820000004)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Piperidine, 1-(4,4-diphenylbutyl)-

Piperidine, 1-(4,4-diphenylbutyl)-

C21H27N (293.21433820000004)


   

Prozapine

Prozapine

C21H27N (293.21433820000004)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

daphenylline

daphenylline

C21H27N (293.21433820000004)


   

1,2-diethenylbenzene: N,N-dimethylmethanamine: styrene

1,2-diethenylbenzene: N,N-dimethylmethanamine: styrene

C21H27N (293.21433820000004)


   

N-(4-Cyclohexylphenyl)-4-isopropylbenzenamine

N-(4-Cyclohexylphenyl)-4-isopropylbenzenamine

C21H27N (293.21433820000004)


   

(2R)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

(2R)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

C21H27N (293.21433820000004)


   

(S)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

(S)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

C21H27N (293.21433820000004)


   

BENZYL-[1-(4-CYCLOHEXYLPHENYL)ETHYL]AMINE

BENZYL-[1-(4-CYCLOHEXYLPHENYL)ETHYL]AMINE

C21H27N (293.21433820000004)


   

Pramiverine

Pramiverine

C21H27N (293.21433820000004)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

Piperidine, 1-(4,4-diphenylbutyl)-

Piperidine, 1-(4,4-diphenylbutyl)-

C21H27N (293.21433820000004)


   

4-Phenyl-1-(4-phenylbutyl)piperidine

4-Phenyl-1-(4-phenylbutyl)piperidine

C21H27N (293.21433820000004)


   

Butriptyline

Butriptyline

C21H27N (293.21433820000004)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Budipine

1-tert-butyl-4,4-diphenylpiperidine

C21H27N (293.21433820000004)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C93038 - Cation Channel Blocker Budipine is an anti-parkinson agent. Budipine also is a substrate of P-glycoprotein (P-gp), is mediated the uptake into the brain by P-gp. Budipine also is N-methyl-d-aspartate (NMDA) antagonist, and has indirect dopaminergic effects through an improved dopamine release, the inhibition of monoamine oxidase type B (MAO-B). Budipine can be used for the research of CNS disorders include Parkinson disease[1].